FDA official logo
GSRS logo
PFDA official logo

TOFACITINIB CITRATE

  • UNII: O1FF4DIV0D
  • Formula: C16H20N6O.C6H8O7
  • Preferred Substance Name: TOFACITINIB CITRATE
  • InChIKey: SYIKUFDOYJFGBQ-YLAFAASESA-N

  • 540737-29-9
  • 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
  • 3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)
  • CP-690
  • CP-690,550-10
  • CP-690550 CITRATE
  • CP-690550-10
  • TASOCITINIB CITRATE
  • TASOCITINIB MONOCITRATE
  • TOFACITINIB CITRATE [JAN]
  • TOFACITINIB CITRATE [ORANGE BOOK]
  • TOFACITINIB CITRATE [USAN]
  • TOFACITINIB CITRATE [WHO-DD]
  • TOFACITINIB MONOCITRATE [MI]
  • XELJANZ
  • XELJANZ XR

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.